Cargando…

B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

BACKGROUND: Vaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefanski, Ana-Luisa, Rincon-Arevalo, Hector, Schrezenmeier, Eva, Karberg, Kirsten, Szelinski, Franziska, Ritter, Jacob, Chen, Yidan, Jahrsdörfer, Bernd, Ludwig, Carolin, Schrezenmeier, Hubert, Lino, Andreia C., Dörner, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063458/ https://www.ncbi.nlm.nih.gov/pubmed/35514962 http://dx.doi.org/10.3389/fimmu.2022.822885

Ejemplares similares

Persistent but atypical germinal center reaction among 3(rd) SARS-CoV-2 vaccination after rituximab exposure
por: Stefanski, Ana-Luisa, et al.
Publicado: (2022)

B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
por: Stefanski, Ana‐Luisa, et al.
Publicado: (2022)

Altered increase in STAT1 expression and phosphorylation in severe COVID‐19
por: Rincon‐Arevalo, Hector, et al.
Publicado: (2021)

Deep Phenotyping of CD11c(+) B Cells in Systemic Autoimmunity and Controls
por: Rincon-Arevalo, Hector, et al.
Publicado: (2021)

Induction of cross-reactive, mucosal anti-SARS-CoV-2 antibody responses in rheumatoid arthritis patients after 3rd dose of COVID-19 vaccination
por: Bondareva, M., et al.
Publicado: (2022)

BTLA Expression and Function Are Impaired on SLE B Cells
por: Wiedemann, Annika, et al.
Publicado: (2021)

CD39 and CD326 Are Bona Fide Markers of Murine and Human Plasma Cells and Identify a Bone Marrow Specific Plasma Cell Subpopulation in Lupus
por: Dang, Van Duc, et al.
Publicado: (2022)

CD27(+)IgD(−) B cells in the peripheral blood of colorectal cancer patients: on anti-tumor or tumor-protective mission?
por: Jahrsdörfer, Bernd, et al.
Publicado: (2014)

Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases
por: Weißenberg, Sarah Y., et al.
Publicado: (2019)

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
por: Schrezenmeier, Eva, et al.
Publicado: (2022)

BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents
por: Jahrsdörfer, Bernd, et al.
Publicado: (2021)

Phorbol-12-myristate-13-acetate is a potent enhancer of B cells with a granzyme B(+) regulatory phenotype
por: Veh, Johanna, et al.
Publicado: (2023)

Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
por: Gatto, Mariele, et al.
Publicado: (2019)

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2020)

SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation
por: Sattler, Arne, et al.
Publicado: (2022)

ATP promotes immunosuppressive capacities of mesenchymal stromal cells by enhancing the expression of indoleamine dioxygenase
por: Lotfi, Ramin, et al.
Publicado: (2018)

Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals
por: Weinstock, Christof, et al.
Publicado: (2021)

BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages
por: Jahrsdörfer, Bernd, et al.
Publicado: (2022)

Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS–CoV–2: Prospects for mass scale immunity-screening in large populations
por: Tsamadou, Chrysanthi, et al.
Publicado: (2022)

Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
por: Körper, Sixten, et al.
Publicado: (2022)

RTX-Toxins
por: Benz, Roland
Publicado: (2020)

Kingella kingae RtxA Cytotoxin in the Context of Other RTX Toxins
por: Filipi, Katerina, et al.
Publicado: (2022)

mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects
por: Fabricius, Dorit, et al.
Publicado: (2021)

SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
por: Seidel, Alina, et al.
Publicado: (2023)

Efficient CRISPR-Cas9-mediated mutagenesis in primary human B cells for identifying plasma cell regulators
por: Le, Tuan Anh, et al.
Publicado: (2022)

Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes
por: Höchsmann, Britta, et al.
Publicado: (2011)

Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients
por: Thole, Linda Marie Laura, et al.
Publicado: (2023)

Rapid Purification of Endotoxin-Free RTX Toxins
por: Stanek, Ondrej, et al.
Publicado: (2019)

An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection
por: Conzelmann, Carina, et al.
Publicado: (2020)

Human CD27+ memory B cells colonize a superficial follicular zone in the palatine tonsils with similarities to the spleen. A multicolor immunofluorescence study of lymphoid tissue
por: Lettau, Marie, et al.
Publicado: (2020)

Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
por: Schrezenmeier, Hubert, et al.
Publicado: (2020)

Calcium-Dependent RTX Domains in the Development of Protein Hydrogels
por: Bulutoglu, Beyza, et al.
Publicado: (2019)

Essential role of calcium in extending RTX adhesins to their target
por: Vance, Tyler D.R., et al.
Publicado: (2020)

Structure–Function Relationships of the Repeat Domains of RTX Toxins
por: Baumann, Ulrich
Publicado: (2019)

RTX Toxins Ambush Immunity’s First Cellular Responders
por: Ristow, Laura C., et al.
Publicado: (2019)

Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial
por: Heinzel, Andreas, et al.
Publicado: (2022)

Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
por: Heinzel, Andreas, et al.
Publicado: (2022)

RTX Toxins of Animal Pathogens and Their Role as Antigens in Vaccines and Diagnostics
por: Frey, Joachim
Publicado: (2019)

P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
por: Greiner, Jochen, et al.
Publicado: (2023)

Analysis of Vibrio cholerae Genome Sequences Reveals Unique rtxA Variants in Environmental Strains and an rtxA-Null Mutation in Recent Altered El Tor Isolates
por: Dolores, Jazel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1l5fdk0u42k45tv6acv45bdvmj